From: The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo
 | Placebo | BLD | R-Ketorolac | BLD | Control | BLD | Reference Range | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
 | Average ± SD | n= | n= | Average ± SD | n= | n= | Average ± SD | n= | n= | Average ± SD | n= |
Albumin (g/dL) | 4.43 ± 0.25 | 10 |  | 4.05 ± 0.40* | 10 |  | 4.06 ± 0.09 | 5 |  | 2.8–4.0 | 113 |
Glucose (mg/dL) | 222.3 ± 54.07 | 10 |  | 287.7 ± 81.31 | 10 |  | 214.20 ± 25.95 | 5 |  | 149–271 | 114 |
Total Bilirubin1 (mg/dL) | 0.17 ± 0.06## | 3 |  | 0.26 ± 0.05 | 9 |  | 0.32 ± 0.04 | 5 |  | 0.2–0.5 | 107 |
Alanine aminotransferase (U/L) | 43.4 ± 19.36 | 10 |  | 32.30 ± 11.35 | 10 |  | 23.80 ± 4.55 | 5 |  | 31–115 | 105 |
Alkaline phosphatase1,2 (U/L) | 16.58 ± 13.09#### | 9 | 3 | 28.97 ± 18.75### | 10 | 2 | 68.6 ± 2.51 | 5 |  | 76–301 | 114 |
Amylase (U/L) | 1027 ± 337 | 10 |  | 1069 ± 264 | 10 |  | 858 ± 90.13 | 5 |  |  |  |
Blood Urea Nitrogen (mg/dL) | 18.5 ± 2.92 | 10 |  | 16.4 ± 2.59 | 10 |  | 19.0 ± 3.61 | 5 |  | 11–39 | 114 |
Calcium (mg/dL) | 11.53 ± 0.56 | 10 |  | 11.58 ± 0.79 | 10 |  | 10.76 ± 0.42 | 5 |  | 9.5–12.1 | 114 |
Creatinin1,2 (mg/dL) | 0.16 ± 0.08 | 7 | 4 | 0.24 ± 0.13 | 9 | 3 | 0.20 ± 0.13 | 5 | 3 | 0.2–0.4 | 107 |
Globulin (g/dL) | 1.5 ± 0.4 | 9 |  | 1.77 ± 0.43 | 10 |  | 1.36 ± 0.18 | 5 |  |  |  |
Phosphorus (mg/dL) | 9.59 ± 0.78 | 10 |  | 9.86 ± 1.90 | 10 |  | 6.65 ± 0.55 | 5 |  | 8.0–15.5 | 114 |
Sodium (mmol/L) | 149 ± 2.98 | 10 |  | 151.3 ± 4.11# | 10 |  | 145.0 ± 4.53 | 5 |  | 140.7–165.1 | 76 |
Total Protein (g/dL) | 5.88 ± 0.36 | 10 |  | 5.79 ± 0.34 | 10 |  | 5.44 ± 0.13 | 5 |  | 4.8–6.6 | 114 |
Mouse Weight (g) | 24.46 ± 1.42 | 10 |  | 23.67 ± 1.30 | 10 |  | 24.28 ± 2.13 | 5 |  |  |  |